The Procter & Gamble Company (PG) financials
NYSE · Consumer Defensive · Household & Personal Products · 104,000 employees · CEO Shailesh G. Jejurikar
- Price
- $161.57 +0.61%
- Market cap
- $374B
- Enterprise value
- $398B
- Last report
- Q1 '27 filed 2026-10-22
- Next report
- 2027-01-21 EPS est. $1.81
Valuation & key figures
- Market cap
- $374B EV $398B
- Revenue
- $87.9B Trailing 12 months
- Revenue growth
- +3% FY2027 consensus
- Profit margin
- 18.2% Net income / revenue, TTM
- P/E
- 23.9× Forward 23.2× (FY2027)
- P/S
- 4.3× Price / sales, TTM
- EV / EBITDA
- 16.3× TTM
- Free cash flow
- $15.3B Trailing 12 months
- Net income
- $16B Trailing 12 months
- Revenue estimate
- $89.9B FY2027 consensus
- Earnings
- 2027-01-21 Revenue est. $22.9B
- Dividend
- $4.32 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-10-22): revenue beat by 2.1%, EPS beat by 6.4%Revenue $23.3B vs $22.8B expected (+2.1%); EPS $2.00 vs $1.88 (+6.4%).
- Revenue growth steady: 4.0% year on yearQ1 '27 revenue $23.3B, against an average of 3.3% over the four quarters before.
- Operating margin 22.6% (TTM), -1.6 pp on a year agoOperating income grew -3.3% while revenue grew 3.5%.
- Capex 5.2% of revenue (a year ago 4.7%)$4.58B invested in the last 4 quarters (+14.9% on a year earlier). Free cash flow $15.3B = 95.7% of net income.
- Returned $15.3B to shareholders = 99.8% of free cash flowBuybacks $5.03B (a year earlier $5.81B), dividends $10.3B, stock-based pay $501M (TTM).
- Diluted share count down 1.2% in a year2.41B diluted shares in Q1 '27, 2.44B a year earlier.
- Net debt $23.6BCash + short-term investments $15.4B, debt incl. leases $38.9B; a year ago net debt $24.8B.
Last quarter: Q1 '27
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q1 '27 | Year ago | Change | |
|---|---|---|---|
| Revenue | $23.3B | $22.4B | +4.0% |
| Gross margin | 49.8% | 51.4% | -1.5 pp |
| Operating income | $5.94B | $5.86B | +1.4% |
| Operating margin | 25.5% | 26.2% | -0.7 pp |
| Net income | $4.73B | $4.75B | -0.4% |
| Diluted EPS | $1.97 | $1.95 | +1.0% |
| Operating cash flow | $5.77B | $5.41B | +6.6% |
| Capex | $1.37B | $1.2B | +13.8% |
| Free cash flow | $4.4B | $4.21B | +4.6% |
| R&D | $0 | $0 | – |
| Stock-based compensation | $98M | $121M | -19.0% |
Reported vs consensus
2026-10-22| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $23.3B | $22.8B | +2.1% |
| EPS (as estimated) | $2.00 | $1.88 | +6.4% |
From the report of 2026-10-22 for Q1 '27: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q1 '27 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Fabric Care And Home Care Segment Member | $8.2B | +5.3% | 35.4% | $30.7B | +3.5% | |
| Baby, Feminine and Family Care Segment Member | $5.32B | +2.9% | 23.0% | $20.6B | +1.2% | |
| Beauty Segment | $4.41B | +6.4% | 19.1% | $16.3B | +7.1% | |
| Health Care Segment Member | $3.32B | +3.0% | 14.3% | $12.6B | +4.0% | |
| Grooming Segment Member | $1.89B | +4.0% | 8.2% | $6.99B | +3.5% |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $19.9B
- Capex
- -$4.58B
- Buybacks
- -$5.03B
- Dividends
- -$10.3B
- Acquisitions
- -$72M
- Net debt issued
- $3.32B
- Stock-based compensation
- $501M
- Free cash flow
- $15.3B
- Returned to shareholders / FCF
- 99.8%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 23.9× | 24.2× | 21.7× – 26.3× |
| EV / EBITDA | 16.3× | 17.3× | 15.6× – 18.1× |
| EV / Sales | 4.5× | 4.7× | 4.4× – 4.9× |
| Price / FCF | 24.4× | 25.3× | 23.2× – 27.8× |
| Price / Book | 7.1× | 7.4× | 6.5× – 7.7× |
| FCF yield | 4.1% | 4.0% | 3.6% – 4.3% |
| Return on invested capital | 14.9% | 15.7% | 15.2% – 16.5% |
| Return on equity | 29.5% | 30.6% | 29.5% – 31.6% |
Analysts
Consensus target $166.78 (+3.2%)
range $149.00 – $190.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2027 | $89.9B | +3.3% | $6.98 | +5.4% | 23.2× | 13 |
| FY2028 | $92.7B | +3.1% | $7.40 | +6.1% | 21.8× | 13 |
| FY2029 | $96B | +3.6% | $7.85 | +6.0% | 20.6× | 5 |
| FY2030 | $99.5B | +3.6% | $8.09 | +3.1% | 20.0× | 3 |
| FY2031 | $100B | +0.9% | $7.69 | -4.9% | 21.0× | 4 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 287 figures The Procter & Gamble Company tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| – | – | – | $41M | -$2M | +2,150.0% | |
| – | – | – | 0.2% | 0.0% | – | |
| – | – | – | $235M | $163M | +44.2% | |
| – | – | – | $3.06B | $2.99B | +2.1% | |
| – | – | – | $1.26B | $1.19B | +5.9% | |
| – | – | – | $365M | $373M | -2.1% | |
| Accounts Payable, Current | $17.1B | $15.6B | +9.3% | $16.3B | $15.2B | +7.1% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $6.62B | $6.49B | +2.1% | $6.06B | $6.19B | -2.1% |
| Accrued Liabilities, Current | $10.9B | $10.8B | +1.4% | $11.1B | $11.3B | -2.0% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $31.8B2026-06-30 | $30.3B | +5.0% | $31.8B | $30.3B | +5.0% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$12.7B | -$12.2B | -4.1% | -$12.5B | -$12.1B | -2.7% |
| Additional Paid in Capital | $69.7B | $68.9B | +1.1% | $69.5B | $68.8B | +1.1% |
| Advertising Expense | – | – | – | $10.2B | $9.2B | +10.9% |
| Amortization of Intangible Assets | $75M | $79M | -5.1% | $308M | $320M | -3.7% |
| Assets | $133B | $128B | +4.3% | $127B | $125B | +1.0% |
| Assets, Current | $32.5B | $27.1B | +19.9% | $26.2B | $25.4B | +3.2% |
| Cash Equivalents, at Carrying Value | $13.7B | $9.9B | +38.4% | $8.7B | $8.3B | +4.8% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $15.4B | $11.2B | +37.5% | $9.94B | $9.56B | +4.0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $5.42B | $1.62B | +235.8% | $386M | $75M | +414.7% |
| Collateral Already Posted, Aggregate Fair Value | $279M | $772M | -63.9% | $260M | $1.1B | -76.4% |
| Commercial Paper | $4.84B2026-06-30 | $4.11B | +17.7% | $4.84B | $4.11B | +17.7% |
| Common Stock, Dividends, Per Share, Declared | $1.09 | $1.06 | +3.0% | $4.26 | $4.08 | +4.5% |
| Common Stock, Par or Stated Value Per Share | $1.002026-06-30 | $1.00 | 0.0% | $1.00 | $1.00 | 0.0% |
| Common Stock, Shares Authorized | 10B2026-06-30 | 10B | 0.0% | 10B | 10B | 0.0% |
| Common Stock, Shares, Issued | 4.01B | 4.01B | 0.0% | 4.01B | 4.01B | 0.0% |
| Common Stock, Value, Issued | $4.01B | $4.01B | 0.0% | $4.01B | $4.01B | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | $24M | $24M | 0.0% | $77M | $87M | -11.5% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $4.54B | $4.74B | -4.1% | $15.7B | $15.7B | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | $4.57B | $4.76B | -4.1% | $15.8B | $15.8B | -0.1% |
| Cost of Goods and Services Sold | $11.7B | $10.9B | +7.3% | $43.4B | $41.2B | +5.3% |
| Current Federal Tax Expense (Benefit) | – | – | – | $2.11B | $2.22B | -5.0% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $1.7B | $1.33B | +27.8% |
| Current Income Tax Expense (Benefit) | – | – | – | $4.18B | $3.95B | +5.8% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $378M | $407M | -7.1% |
| Debt, Current | $17B | $11.6B | +46.4% | $11.3B | $9.51B | +18.7% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | -$27M | $9M | -400.0% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $98M | $146M | -32.9% |
| Deferred Income Tax Expense (Benefit) | $115M | $53M | +117.0% | $51M | $149M | -65.8% |
| Deferred Income Tax Liabilities, Net | $5.95B | $5.89B | +1.0% | $5.76B | $5.77B | -0.2% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | -$21M | -$5M | -320.0% |
| Deferred Tax Assets, Net of Valuation Allowance | $4.93B2026-06-30 | $4.92B | +0.2% | $4.93B | $4.92B | +0.2% |
| Deferred Tax Assets, Other | $832M2026-06-30 | $758M | +9.8% | $832M | $758M | +9.8% |
| Deferred Tax Assets, Other Tax Carryforwards | $769M2026-06-30 | $857M | -10.3% | $769M | $857M | -10.3% |
| Deferred Tax Assets, Property, Plant and Equipment | $266M2026-06-30 | $230M | +15.7% | $266M | $230M | +15.7% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | $466M2026-06-30 | $445M | +4.7% | $466M | $445M | +4.7% |
| Deferred Tax Assets, Unrealized Losses on Trading Securities | $144M2026-06-30 | $358M | -59.8% | $144M | $358M | -59.8% |
| Deferred Tax Assets, Valuation Allowance | $330M2026-06-30 | $293M | +12.6% | $330M | $293M | +12.6% |
| Deferred Tax Liabilities, Goodwill and Intangible Assets | $5.44B2026-06-30 | $5.48B | -0.6% | $5.44B | $5.48B | -0.6% |
| Deferred Tax Liabilities, Leasing Arrangements | $194M2026-06-30 | $209M | -7.2% | $194M | $209M | -7.2% |
| Deferred Tax Liabilities, Net | $9.11B2026-06-30 | $9.05B | +0.6% | $9.11B | $9.05B | +0.6% |
| Deferred Tax Liabilities, Other | $630M2026-06-30 | $492M | +28.0% | $630M | $492M | +28.0% |
| Deferred Tax Liabilities, Property, Plant and Equipment | $1.61B2026-06-30 | $1.55B | +3.8% | $1.61B | $1.55B | +3.8% |
| Deferred Tax Liabilities, Undistributed Foreign Earnings | $158M2026-06-30 | $131M | +20.6% | $158M | $131M | +20.6% |
| Deferred Tax Liabilities, Unrealized Gains on Trading Securities | $187M2026-06-30 | $96M | +94.8% | $187M | $96M | +94.8% |
| Defined Benefit Plan, Accumulated Benefit Obligation | $11.8B2026-06-30 | $12.5B | -5.6% | $11.8B | $12.5B | -5.6% |
| Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets | $5.09B2026-06-30 | $5.07B | +0.4% | $5.09B | $5.07B | +0.4% |
| Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation | $7.38B2026-06-30 | $8.18B | -9.7% | $7.38B | $8.18B | -9.7% |
| Defined Contribution Plan, Cost | – | – | – | $534M | $534M | 0.0% |
| Depreciation, Depletion and Amortization | $810M | $761M | +6.4% | $3.16B | $2.85B | +11.0% |
| Derivative Asset | $223M | $11M | +1,927.3% | $176M | $19M | +826.3% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-K 2026-06-30, 10-Q 2026-03-31, 10-Q 2025-12-31, 10-Q 2025-09-30, 10-K 2025-06-30, 10-Q 2025-03-31, 10-Q 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-01